Camber Spine Receives FDA Clearance for ENZA Zero Profile ALIF Device

Camber Spine Technologies received FDA 510(k) clearance to market the ENZA™ Zero Profile Anterior Interbody Fusion (ALIF) system.

ENZA is intended to treat degenerative disc disease, for use with bone graft and supplemental fixation systems. The product was co-developed with the Institute for Musculoskeletal Science & Education.


document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us